Freddy Sanchez is playing third base on rehab assignment

6 Comments

Pablo Sandoval being out 4-6 weeks with a fractured hamate bone has the Giants thinking about creative ways to replace him, which is why second baseman Freddy Sanchez played third base yesterday on his minor-league rehab assignment.

Sanchez has suffered numerous setbacks trying to recover from shoulder problems, so counting on him returning as a productive player is iffy enough without a position switch, but Andrew Baggarly of CSNBayArea.com reports that the 34-year-old “went to manager Bruce Bochy last week and volunteered to try playing third base.”

Post-surgery arm strength was already going to be an issue for Sanchez at second base and last time he played third base was 2006, but he’s logged more than 1,300 career innings as the position and claims the longer throws are somehow easier on his shoulder.

Of course, it’s also worth noting that Ryan Theriot and Emmanuel Burriss aren’t exactly putting up huge numbers splitting time at second base, so Sanchez returning as a third baseman might solve one problem while leaving another.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.